throbber
Trials@uspto.gov
`571-272-7822
`
`Paper 29
`Entered: April 29, 2022
`
`UNITED STATES PATENT AND TRADEMARK OFFICE
`
`BEFORE THE PATENT TRIAL AND APPEAL BOARD
`
`APPLE INC.,
`Petitioner,
`v.
`MASIMO CORPORATION,
`Patent Owner.
`
`IPR2020-01524
`Patent 10,433,776 B2
`
`
`
`
`
`
`
`
`
`Before JOSIAH C. COCKS, ROBERT L. KINDER, and
`AMANDA F. WIEKER, Administrative Patent Judges.
`KINDER, Administrative Patent Judge.
`
`
`JUDGMENT
`Final Written Decision
`Determining No Challenged Claims Unpatentable
`35 U.S.C. § 318(a)
`
`
`
`
`
`
`
`
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`
`I.
`
`INTRODUCTION
`
`Background
`A.
`Apple Inc. (“Petitioner”) filed a Petition requesting an inter partes
`review of claims 1–16 (“challenged claims”) of U.S. Patent
`No. 10,433,776 B2 (Ex. 1001, “the ’776 patent”). Paper 2 (“Pet.”). Masimo
`Corporation (“Patent Owner”) waived filing a Preliminary Response.
`Paper 6. We instituted an inter partes review of all challenged claims on all
`asserted grounds of unpatentability, pursuant to 35 U.S.C. § 314. Paper 7
`(“Inst. Dec.”).
`After institution, Patent Owner filed a Response (Paper 15, “PO
`Resp.”) to the Petition, Petitioner filed a Reply (Paper 18, “Pet. Reply”), and
`Patent Owner filed a Sur-reply (Paper 20, “Sur-reply”). An oral hearing was
`held on January 19, 2022, and a transcript of the hearing is included in the
`record. Paper 28 (“Tr.”).
`We issue this Final Written Decision pursuant to 35 U.S.C. § 318(a)
`and 37 C.F.R. § 42.73. Based on the record before us and for the reasons set
`forth below, Petitioner has not met its burden of showing, by a
`preponderance of the evidence, that any challenged claim of the ’776 patent
`is unpatentable.
`
`Related Matters
`B.
`The parties identify the following matters related to the ’776 patent:
`Masimo Corporation v. Apple Inc., Civil Action No. 8:20-cv-00048
`(C.D. Cal.) (filed Jan. 9, 2020);
`Apple Inc. v. Masimo Corporation, IPR2020-01520 (PTAB
`Aug. 31, 2020) (challenging claims of U.S. Patent No. 10,258,265 B1);
`
`2
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`
`Apple Inc. v. Masimo Corporation, IPR2020-01521 (PTAB
`Sept. 2, 2020) (challenging claims of U.S. Patent No. 10,292,628 B1);
`Apple Inc. v. Masimo Corporation, IPR2020-01523 (PTAB
`Sept. 9, 2020) (challenging claims of U.S. Patent No. 8,457,703 B2);
`Apple Inc. v. Masimo Corporation, IPR2020-01526 (PTAB
`Aug. 31, 2020) (challenging claims of U.S. Patent No. 6,771,994 B2);
`Apple Inc. v. Masimo Corporation, IPR2020-01536 (PTAB
`Aug. 31, 2020) (challenging claims of U.S. Patent No. 10,588,553);
`Apple Inc. v. Masimo Corporation, IPR2020-01537 (PTAB
`Aug. 31, 2020) (challenging claims of U.S. Patent No. 10,588,553);
`Apple Inc. v. Masimo Corporation, IPR2020-01538 (PTAB
`Sept. 2, 2020) (challenging claims of U.S. Patent No. 10,588,554 B2); and
`Apple Inc. v. Masimo Corporation, IPR2020-01539 (PTAB
`Sept. 2, 2020) (challenging claims of U.S. Patent No. 10,588,554 B2).
`Pet. 68; Paper 3, 2–3.
`
`The parties further identify certain pending patent applications, as
`well as other issued applications, that claim priority to, or share a priority
`claim with, the ’776 patent. Pet. 68; Paper 3, 1.
`
`The ’776 Patent
`C.
`The ’776 patent is titled “Low Power Pulse Oximeter,” and issued on
`October 8, 2019, from U.S. Patent Application No. 16/174,144, filed
`October 29, 2018. Ex. 1001, codes (21), (22), (45), (54). The ’776 patent
`claims priority through a series of continuation applications to Provisional
`Application No. 60/302,564, filed July 2, 2001. Id. at codes (60), (63).
`The ’776 patent relates to a pulse oximeter that may reduce power
`consumption in the absence of certain parameters that may be monitored to
`
`3
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`trigger or override the reduced power consumption state. Id. at code (57).
`“In this manner, a pulse oximeter can lower power consumption without
`sacrificing performance during, for example, high noise conditions or
`oxygen desaturations.” Id.
`As depicted below, the low power pulse oximeter has signal
`processor (340) that derives physiological measurements (342), including
`oxygen saturation, pulse rate, and plethysmograph, from input sensor
`signal (322). Ex.1001, 4:65–5:16, Figs. 3, 4.
`
`
`Figure 3 illustrates a top-level block diagram of a low power pulse oximeter.
`Id. at 4:41–42. Signal processor (340) may also derive signal
`statistics (344), such as signal strength, noise, and motion artifact. Id. at
`5:16–17, Figs. 3, 4. Physiological measurements (342) and signal
`statistics (344) may be input into sampling controller (360), which outputs
`sampling controls (362) that in turn are used to regulate pulse oximeter
`power dissipation by causing sensor interface (320) to vary the sampling
`characteristics of sensor port (302) and by causing signal processor (340) to
`
`4
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`vary its sample processing characteristics. Id. at 5:17–26, Figs. 3, 4.
`According to the ’776 patent, power dissipation “is responsive not only to
`output parameters, such as the physiological measurements 342, but also to
`internal parameters, such as the signal statistics 344.” Id. at 5:26–29.
`The pulse oximeter uses the physiological measurements and signal
`statistics to determine “the occurrence of an event or low signal quality
`condition.” Ex. 1001, 6:28–31. An event determination is based upon the
`physiological measurements and “may be any physiological-related
`indication that justifies the processing of more sensor samples and an
`associated higher power consumption level, such as oxygen desaturation, a
`fast or irregular pulse rate or an unusual plethysmograph waveform.” Id. at
`6:31–37. A low signal quality condition is based upon the signal statistics
`and “may be any signal-related indication that justifies the processing or
`more sensor samples and an associated higher power consumption level,
`such as a low signal level, a high noise level or motion artifact.” Id. at 6:37–
`42.
`
`The pulse oximeter “utilizes multiple sampling mechanisms to alter
`power consumption.” Ex. 1001, 5:62–64. One sampling mechanism is “an
`emitter duty cycle control” that “determines the duty cycle of the current
`supplied by the emitter drive outputs 482 to both red and IR sensor
`emitters.” Id. at 5:64–6:2. The sampling mechanisms “modify power
`consumption by, in effect, increasing or decreasing the number of input
`samples received and processed.” Id. at 6:12–14. “Sampling, including
`acquiring input signal samples and subsequent sample processing, can be
`reduced during high signal quality periods and increased during low signal
`quality periods or when critical measurements are necessary.” Id. at 6:14–
`
`5
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`18. “In conjunction with an intermittently reduced duty cycle or as an
`independent sampling mechanism, there may be a ‘data off’ time period
`longer than one drive current cycle where the emitter drivers . . . are turned
`off.” Id. at 7:11–15. The occurrence of an event or low signal quality
`triggers a higher duty sensor sampling, allowing high fidelity monitoring of
`the event and providing a larger signal-to-noise ratio. Id. at 8:47–61.
`
`Illustrative Claim
`D.
`Of the challenged claims, claims 1 and 11 are independent. Claim 1 is
`illustrative and is reproduced below.
`1.[p] A method of operating a patient monitor configured
`to monitor at least a pulse rate of a patient by processing signals
`responsive to light attenuated by body tissue, the method
`comprising:
`[a] operating the patient monitor according to a first
`control protocol, wherein said operating includes activating a
`first control protocol light source in accordance with the first
`control protocol, the first control protocol light source including
`one or more of a plurality of light sources;
`when operating according to the first control protocol,
`calculating, by the patient monitor, measurement values of the
`pulse rate, the measurement values responsive to light from the
`first control protocol light source, detected by a detector of an
`optical sensor after attenuation by body tissue of the patient using
`the patient monitor;
`[b] generating a trigger signal, wherein generating said
`trigger signal is responsive to at least one of: a comparison of
`processing characteristics to a predetermined threshold, a
`physiological event, or signal quality characteristics of signals
`received from the detector;
`[c] in response to receiving the trigger signal, operating the
`patient monitor according to a second control protocol different
`
`6
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`
`from the first control protocol, wherein said operating includes
`activating a second control protocol light source in accordance
`with the second control protocol, the second control protocol
`light source including one or more of the plurality of light
`sources; and
`when operating the patient monitor according to the
`second control protocol, calculating the measurement values of
`the pulse rate, the measurement values responsive to light from
`the second control protocol light source, detected by the detector
`after attenuation by the body tissue of the patient using the
`patient monitor,
`[d] wherein said operating of the patient monitor
`according to the first control protocol operates the first control
`protocol light source according to a first duty cycle and said
`operating of the patient monitor according to the second control
`protocol operates the second control protocol light source
`according to a second duty cycle, wherein power consumption of
`the first control protocol light source according to the first duty
`cycle is different than power consumption of the second control
`protocol light source according to the second duty cycle.
`Ex. 1001, 11:40–12:21 (bracketed identifiers p–d added). Independent
`claim 11 is an apparatus claim that includes limitations substantially similar
`to limitations [a]–[d] of claim 1. Id. at 12:60–14:9.
`
`Applied References
`E.
`Petitioner relies upon the following references:
`Richardson et al., U.S. Patent No. 5,555,882, filed
`August 24, 1994, issued September 17, 1996 (Ex. 1004,
`“Richardson”);
`Bindszus et al., U.S. Patent No. 6,178,343 B1, filed
`May 20, 1999, issued January 23, 2001 (Ex. 1005, “Bindszus”); and
`Turcott, U.S. Patent No. 6,527,729 B1, filed October 11, 2000,
`issued March 4, 2003 (Ex. 1006, “Turcott”).
`Pet. 3–4.
`
`7
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`
` Petitioner also submits, inter alia, the Declaration of Brian W.
`Anthony, Ph.D. (Ex. 1003). Patent Owner submits, inter alia, the
`Declaration of Vijay K. Madisetti, Ph.D. (Ex. 2002). The parties also
`provide deposition testimony from Dr. Anthony and Dr. Madisetti, including
`from this proceeding and others. Exs. 1038, 2005, 2006.
`
`Asserted Grounds of Unpatentability
`F.
`We instituted an inter partes review based on the following grounds.
`Inst. Dec. 9, 23.
`
`Claims Challenged
`1–8, 11–16
`1–9, 11–16
`
`35 U.S.C.

`103
`103
`
`9, 10
`
`1–9, 11–16
`
`1–9, 11–16
`
`9, 10
`
`103
`
`103
`
`103
`
`103
`
`Reference(s)/Basis
`Richardson (first mapping)
`Richardson (second mapping)
`Richardson (either mapping)
`and Bindszus
`Richardson and Turcott (first
`mapping)
`Richardson and Turcott (second
`mapping)
`Richardson and Turcott (either
`mapping) and Bindszus
`
`II. DISCUSSION
`Claim Construction
`A.
`For petitions filed on or after November 13, 2018, a claim “shall be
`construed using the same claim construction standard that would be used to
`construe the claim in a civil action under 35 U.S.C. § 282(b).” 37 C.F.R.
`§ 42.100(b) (2019). Petitioner submits that no claim term requires express
`construction. Pet. 7. Nonetheless, we determine that the parties’ briefing
`
`8
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`identifies certain aspects of the claim language that implicate claim
`construction, as discussed below.
`
`1. Whether the “first duty cycle” must be different from the “second duty
`cycle.”
`Each independent claim requires “a first duty cycle” and “a second
`duty cycle.” For example, claim 1 requires in pertinent part:
`wherein said operating of the patient monitor according to the
`first control protocol operates the first control protocol light
`source according to a first duty cycle and said operating of the
`patient monitor according to the second control protocol operates
`the second control protocol light source according to a second
`duty cycle.
`
`Ex. 1001, 12:11–16 (emphases added), 14:1–4 (claim 11).
`Petitioner has based its patentability analysis on two alternative claim
`interpretations (two distinct “mappings”) of the claim limitations related to a
`“first duty cycle” and “second duty cycle.” See Pet. 3, 16. The first
`mapping, which Petitioner classifies as the proper construction, requires that
`the first and second duty cycles be different. Pet. 16 (“Accordingly,
`Richardson teaches operating the patient monitor according to different duty
`cycles, under the proper construction of 1[d].” (emphasis added)), Pet. 50
`(“[u]nder the proper construction of 1[d] requiring a different duty cycle for
`operating the infrared light source in State 2 than the duty cycle for
`operating the infrared or red light source in State 1”), 56 (similar argument).
`Petitioner argues that under a proper construction, the first and second duty
`cycles cannot be identical, but the Petition does not provide any argument or
`basis for this reasoning.
`Petitioner, in an alternative mapping, then posits a second claim
`interpretation theory for the “first duty cycle” and “second duty cycle”
`
`9
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`limitations in which the first and second duty cycles need not be different.
`Pet. 30. Specifically, Petitioner argues, “Richardson teaches this limitation
`under an alternate construction of this limitation that does not require
`different duty cycles for the first duty cycle and the second duty cycle.” Id.
`Patent Owner, relying on the testimony of Dr. Madisetti, contends that
`the Board should construe the “first duty cycle” to be different from the
`“second duty cycle,” consistent with Petitioner’s first mapping. PO Resp. 22
`(citing Ex. 2002 ¶¶ 48–53). Patent Owner argues the Specification of the
`’776 patent requires different first and second duty cycles whereas claims 1
`and 11 use “first” and “second” to distinguish the duty cycles. Id. at 23
`(citing Merck & Co. v. Teva Pharms. USA, Inc., 395 F.3d 1364, 1372 (Fed.
`Cir. 2005) (“A claim construction that gives meaning to all the terms of the
`claim is preferred over one that does not do so.”). Patent Owner contends
`that “[c]laims 1 and 11 further clarify that one of the differences between the
`first and second control protocols are the duty cycles.” Id. (citing Ex. 1001,
`12:11–21).
`During the oral hearing, Petitioner conceded that it was now accepting
`the position that the first and second duty cycle must be different. Tr. 6:1–7
`(Petitioner’s counsel stating that “the parties agree that the claims require the
`first and second duty cycle to be different”).
`We determine that the surrounding claim language and the
`Specification of the ’776 patent support the now agreed upon interpretation
`that the first and second duty cycle must be different. See Ex. 1001, 11:45–
`46, 11:63–65, 12:11–21, 6:64–7:2 (distinguishing constant duty cycle pulse
`oximeters), 7:2–4, 8:4–24, Fig. 8.
`
`10
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`
`As discussed more below, Petitioner has conceded that the grounds of
`unpatentability based upon its second mapping of Richardson are no longer
`viable under the interpretation that the first and second duty cycle must be
`different. See Tr. 6:8–9, 27:4–24; Pet. 16, 26. Based on Petitioner’s
`concession, our analysis below focuses on those arguments directed to the
`first mapping of Richardson – “[t]he first mapping assumes that the claims
`require the first and second duty cycles to be different.” Tr. 6:2–3.
`
`2.
`
`Construction of “duty cycle” and whether the “duty cycle” can be
`0%.
`Patent Owner requests that we “construe ‘duty cycle’ to mean ‘the
`ratio of operating time (or on time) of a light source to the total time period
`during which the light source is intermittently operated, expressed as a
`percentage.’” PO Resp. 17 (citing Ex. 2002 ¶ 36). Further, according to
`Patent Owner, “[t]he ‘first duty cycle’ and ‘second duty cycle’ cannot be 0%
`based on the claims and ’776 patent specification.” Id. at 19 (citing
`Ex. 2002 ¶¶ 40–47).
`Patent Owner contends that the person of ordinary skill in the art
`would have understood “duty cycle” to be “the ratio of operating time to
`total elapsed time of a device that operates intermittently, expressed as a
`percentage,” because “[t]he ’776 patent consistently describes the ‘duty
`cycle’ as the ratio of the operating time (or on time) of the red and infrared
`LEDs to the total time period during which the LEDs are intermittently
`operated, expressed as a percentage.” PO Resp. 17–18 (citing Ex. 2004,
`225; Ex. 2002 ¶¶ 37, 39; Ex. 1001, 2:43–44). Patent Owner notes that the
`’776 patent discloses a method of reducing the power consumption of a
`patient monitor by “intermittently reducing the drive current duty cycle.” Id.
`
`11
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`(quoting Ex. 1001, 6:59–7:11). Patent Owner notes that “[t]he ‘drive
`current’ is the current supplied by the red and infrared LED drivers (also
`called the ‘emitter drivers’)”, and “[t]he LEDs operate (i.e., are turned on
`and emit light) when the LED drivers supply current.” Id. at 18 (citing
`Ex. 1001, 2:43–44, 8:16–20; Figs. 4, 8).
`Patent Owner relies on Figure 5 of the ’776 patent, seen below, which
`“illustrates an ‘emitter driver output current’ versus time profile for a pulse
`oximeter.” PO Resp. 18 (quoting Ex. 1001, 6:59–60).
`
`
`Patent Owner’s annotated Figure 5 depicts the LEDs operating in high duty
`cycle state 502 (red) and the LEDs operating in a low duty cycle state 504
`(green). Id. According to Patent Owner, the illustration shows that when
`the LEDs are operating in a high duty cycle, they receive current from the
`emitter driver and are operating (i.e., are turned on and emit light) for 25%
`of the total time period during which the LEDs are intermittently operated,
`and conversely, when the LEDS are operating in a low duty cycle, the LEDs
`receive current and operate (i.e., are turned on and emit light) for 3.125% of
`the total time period during which the LEDs are intermittently operated. Id.
`at 19 (citing Ex. 1001, 6:58–61, 7:4–8, 8:15–24, Fig. 8). Patent Owner thus
`
`12
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`contends that the ’776 patent uses “duty cycle” to mean “the ratio of
`operating time to total elapsed time of a device that operates intermittently,
`expressed as a percentage.” Id. (citing Ex. 2002 ¶¶ 37–39).
`As to Patent Owner’s contention that the first duty cycle and second
`duty cycle cannot be 0%, Patent Owner first looks to the surrounding
`language of claim 1, and notes it “requires ‘operating the patient monitor
`according to a first control protocol,’ where the first control protocol
`‘operates the first control protocol light source according to a first duty
`cycle.’” PO Resp. 20 (quoting Ex. 1001, 11:45–46, 12:11–13). Patent
`Owner next relies on the claim language “that ‘when operating according to
`the first control protocol,’ the patient monitor calculates ‘measurement
`values of the pulse rate’ that are ‘responsive to light from the first control
`protocol light source.’” Id. (quoting Ex. 1001, 11:51–57). “Thus,”
`according to Patent Owner, the claims “require the ‘first control protocol
`light source’ to generate light so that the patient monitor can calculate the
`pulse rate based on the light.” Id. (citing Ex. 2002 ¶ 41). Patent Owner
`reasons that “if the first control protocol light source had a duty cycle of 0%,
`the light source would be inactive and would not generate light.” Id. (citing
`Ex. 2002 ¶ 42). Accordingly, if the first control protocol light source had a
`duty cycle of 0%, Patent Owner contends “the monitor could not calculate
`the ‘measurement values of the pulse rate’ as required by claims 1 and 11,”
`and, therefore, “the ‘first duty cycle’ must be a percentage greater than zero
`so that the first control protocol light source generates light, thereby
`permitting the monitor to calculate ‘measurement values of pulse rate’
`responsive to that light.” Id.
`
`13
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`
`Patent Owner notes that the claim language related to the second
`control protocol operating the second control protocol light source is similar
`to that above, such that the patient monitor calculates “measurement values
`of the pulse rate” that are “responsive to light from the second control
`protocol light source.” PO Resp. 20–21 (quoting Ex. 1001, 12:4–10).
`Patent Owner similarly argues that “the ‘second duty cycle’ must be a
`percentage greater than zero so that the second control protocol light source
`generates light, thereby permitting the monitor to calculate ‘measurement
`values of pulse rate’ responsive to that light.” Id. at 21.
`Next, Patent Owner notes that the Specification “never mentions a
`duty cycle of 0%,” but instead the Specification “consistently describes a
`patient monitor having high and low duty cycles greater than 0%.” Id.
`(citing Ex. 1001, 2:39–44, 7:4–11, 8:14–15; Ex. 2002 ¶¶ 45–46). Patent
`Owner points out that the duty cycle of the preferred embodiment “is varied
`within a range from about 25% to about 3.125%.” Id. (quoting Ex. 1001,
`7:4–9).
`Next, Patent Owner distinguishes the “data off state” from the duty
`cycle. PO Resp. 21–22. According to Patent Owner, the “data off state” is
`the situation of having the LEDs inactive for longer than one cycle. Id.
`(citing Ex. 1001, 7:11–15; Ex. 2002 ¶ 46). Patent Owner argues that the
`Specification distinguishes the data off state from the first and second duty
`cycles and further relies on the language stating “[i]n conjunction with an
`intermittently reduced duty cycle or as an independent sampling mechanism,
`there may be a ‘data off’ time period longer than one drive current cycle
`where the emitter drivers are turned off.” Id. at 22 (quoting Ex. 1001, 7:11–
`15 (emphasis omitted)) (citing Ex. 1001, 8:14–15, 8:16–32, 8:47–61).
`
`14
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`Patent Owner contends this language is “an example of first and second duty
`cycles in conjunction with a data off state,” and “[a] data off state is a
`different state where the light sources are turned off for more than one
`period.” Tr. 25:20–26:5. Further, Patent Owner contends that “in
`conjunction with” means that “it works together with.” Tr. 32:2–3, 32:11–
`14 (“I think it has its plain meaning. It means together with. They operate
`together with each other. . . . It doesn’t mean that they operate
`simultaneously and it doesn’t mean that they are replacements for each
`other.”).
`Petitioner contends that the “first duty cycle” can be 0%. Pet.
`Reply 1. Petitioner does not expressly disagree with the proposed
`construction of duty cycle to require a ratio of operating time, but Petitioner
`is firm that the duty cycle may be calculated to be zero percent. See id. at 1–
`3; Tr. 42:3–20 (“[T]hey’re adding on this requirement that that ratio can’t be
`zero. It’s not like you have a ratio of zero to some positive value is
`undefined. That actually you can compute that, it’s zero. So, I don’t see
`how the restriction that it can’t be zero flows from an argument that it has to
`be a ratio.”). Petitioner contends that nothing in the claim language or
`specification of the ’776 patent supports a restriction that the “first duty
`cycle” cannot be 0%. Pet. Reply 1.
`According to Petitioner, the claim requirements identified by Patent
`Owner are still satisfied when the “first duty cycle” is 0%. Id. More
`“[s]pecifically, claims 1 and 11 recite ‘the first control protocol light source
`including one or more of a plurality of light sources’ and ‘operating of the
`patient monitor according to the first control protocol operates the first
`control protocol light source according to a first duty cycle.’” Id. (quoting
`
`15
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`Ex. 1001, 11:48–50, 12:11–13, 13:5–7, 13:35–14:1). Petitioner contends
`that “[a]s long as one of the plurality of light sources is operated at a duty
`cycle greater than 0%, the patient monitor can calculate measurement values
`of the pulse rate from that one light source even if another of the plurality of
`light sources is operated at a duty cycle of 0%.” Id. at 2.
`Petitioner next points to the claim language of dependent claims 6 and
`15 that requires a “data off state.” Pet. Reply 2. Petitioner argues that the
`language, “operating the patient monitor in accordance with the first control
`protocol comprises operating the first control protocol light source in a data
`off state,” allows for the “first duty cycle” to be 0%. Id. (quoting Ex. 1001,
`12:43–46, 14:23–26). According to Petitioner, the “first duty cycle”
`corresponds to “a data off state” and a “light source operating with a duty
`cycle of 0% is operating in a data off state.” Id.
`Petitioner reads the language from the Specification stating that
`operating in the data off state can be “[i]n conjunction with an intermittently
`reduced duty cycle,” as allowing the data off state and the reduced duty
`cycle to occur at the same time; i.e., the reduced duty cycle can correspond
`to the data off state. Id. at 3 (citing Ex. 1001, 7:11–15) (emphasis omitted).
`Further, Petitioner contends that the Specification describes three control
`states: “high duty cycle,” “low duty cycle,” and “data off,” but the
`Specification “does not indicate which control state corresponds to the
`claimed ‘first duty cycle’ and ‘second duty cycle.’” Id. (citing Ex. 1001,
`8:14–32, 8:47–61).
`Based on the final record, we find Patent Owner’s proposed
`interpretation of “duty cycle” persuasive. The evidence cited supports “duty
`cycle” to mean “the ratio of operating time (or on time) of a light source to
`
`16
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`the total time period during which the light source is intermittently operated,
`expressed as a percentage.” See Ex. 2002 ¶ 36 (relying on an electronics
`dictionary and testifying as to how the ’776 patent uses “duty cycle”
`consistent with its plain and ordinary meaning to require a ratio of operating
`time to total elapsed time). We are persuaded by the Specification of the
`’776 patent describing the “duty cycle” as the ratio of the operating time (or
`on time) of the red and infrared LEDs to the total time period during which
`the LEDs are intermittently operated, expressed as a percentage. See
`Ex. 1001, 2:43–44; Ex. 2004, 225; Ex. 2002 ¶¶ 37, 39. The duty cycle is
`described as consistently being “in the range of about 3.125% to about
`25%.” Ex. 1001, 2:43–44, Figs. 5, 8.
`The weight of the evidence, including the claim language and
`Specification, convinces us that neither the first nor the second duty cycles
`can be 0%. The claims require the first and second control protocol light
`sources to generate light so that the patient monitor can calculate a pulse rate
`based on the light. See Ex. 1001, 11:45–12:21 (“when operating according
`to the first control protocol, calculating . . . measurement values of the pulse
`rate, . . . responsive to light from the first control protocol light source” and
`“calculating the measurement values of the pulse rate, . . . responsive to light
`from the second control protocol light source”); Ex. 2002 ¶¶ 41, 42. The
`first and second duty cycles cannot be 0% because the light sources of the
`first and second control protocol light source would not generate light to
`enable pulse rate calculation as required by the claims. See Ex. 2002 ¶ 42
`(“[I]f the first control protocol light source had a duty cycle of 0%, the light
`source would be inactive and would not generate light. If the light source
`did not generate light the monitor could not calculate the ‘measurement
`
`17
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`values of the pulse rate” as required by claims 1 and 11.”) ¶ 44 (“[A]s with
`the first control protocol light source, if the second control protocol light
`source had a duty cycle of 0%, the light source would be inactive and would
`not generate light.”); Ex. 1001, 12:12–13.
`Based on the context of the claim language, and supporting
`explanations in the Specification, we determine that a 0% duty cycle is not
`within the scope of the invention. As explained persuasively by
`Dr. Madisetti:
`If the light source did not generate light, the monitor could not
`calculate the “measurement values of the pulse rate” as required
`by claims 1 and 11. For this reason, the “first duty cycle” must
`be a percentage greater than zero (i.e., it cannot be 0%) so that
`the first control protocol light source generates light, thereby
`permitting the monitor to calculate “measurement values of pulse
`rate” responsive to that light.
`
`Ex. 2002 ¶ 42. See also Tr. 44:14–20 (“[T]he claims require that when
`you’re operating according to the first control protocol you must calculate
`measurement values of the pulse rate and when you’re operating according
`to the second control protocol, . . . you must calculate the measurement
`values of the pulse rate and the problem is if the LEDs are turned off you
`cannot calculate the measurement value.”).
`We find unpersuasive Petitioner’s reliance on the claim language
`requiring “the first control protocol light source including one or more of a
`plurality of light sources,” to argue that as long as one of the plurality of
`light sources is operated at a duty cycle greater than 0%, the patient monitor
`can calculate measurement values of the pulse rate from that one light
`source. See Pet. Reply 1–2 (“As long as one of the plurality of light sources
`is operated at a duty cycle greater than 0%, the patient monitor can calculate
`
`18
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`measurement values of the pulse rate from that one light source even if
`another of the plurality of light sources is operated at a duty cycle of 0%.”).
`As Patent Owner notes, “[t]he claims do not state that ‘one or more of a
`plurality of light sources’ operate according to a first duty cycle,” but
`instead, “the claims state, ‘the first control protocol operates the first control
`protocol light source according to a first duty cycle.’” Sur-reply 2 (emphasis
`omitted). Thus, we agree with Patent Owner that the claims presume that
`the individual light source(s) that comprise the first protocol light source
`operate as a unit according to the same, first duty cycle. See id.
`Dr. Madisetti testifies persuasively that a person of ordinary skill in the art
`would not have understood a “first duty cycle” or a “second duty cycle” to
`encompass two distinct percentages of on time for the different LEDs that
`may make up the “protocol light source.” Ex. 2002 ¶ 68. For example, the
`Specification of the ’776 patent consistently describes patient monitors
`having multiple LEDs, which operate as a unit at the same low or high duty
`cycle. See Ex. 1001, 6:59–7:18, Fig. 5. As noted by Patent Owner, the
`’776 patent does not disclose monitors that simultaneously drive multiple
`LEDs at different duty cycles. See Sur-reply 3; Ex. 2002 ¶¶ 45–46. We also
`agree with Dr. Madisetti that a person of ordinary skill in the art “would not
`have understood ‘duty cycle’ to refer to the additive percentages of ‘on time’
`of two drive signals that drive different LEDs.” Ex. 2002 ¶ 68.
`The “data off” state claimed in claims 6 and 15 does not support
`Petitioner’s position that the first duty cycle can be 0%. The ’776 patent
`distinguishes between high and low duty cycles and a “data off state” where
`the LEDs are inactive for longer than one cycle. See Ex. 2002 ¶¶ 45–46. We
`do not agree with Petitioner that to satisfy claims 6 and 15, the first duty
`
`19
`
`

`

`IPR2020-01524
`Patent 10,433,776 B2
`
`cycle can be in a data off state. Pet. Reply 2. Notably, claims 6 and 15 do
`not state that the first duty cycle is a data off state, as Petitioner argues.
`Rather, claims 6 and 15 use the word “comprises,” which requires operating
`according to the first control protocol to encompass operating the first
`control protocol light source both “ac

This document is available on Docket Alarm but you must sign up to view it.


Or .

Accessing this document will incur an additional charge of $.

After purchase, you can access this document again without charge.

Accept $ Charge
throbber

Still Working On It

This document is taking longer than usual to download. This can happen if we need to contact the court directly to obtain the document and their servers are running slowly.

Give it another minute or two to complete, and then try the refresh button.

throbber

A few More Minutes ... Still Working

It can take up to 5 minutes for us to download a document if the court servers are running slowly.

Thank you for your continued patience.

This document could not be displayed.

We could not find this document within its docket. Please go back to the docket page and check the link. If that does not work, go back to the docket and refresh it to pull the newest information.

Your account does not support viewing this document.

You need a Paid Account to view this document. Click here to change your account type.

Your account does not support viewing this document.

Set your membership status to view this document.

With a Docket Alarm membership, you'll get a whole lot more, including:

  • Up-to-date information for this case.
  • Email alerts whenever there is an update.
  • Full text search for other cases.
  • Get email alerts whenever a new case matches your search.

Become a Member

One Moment Please

The filing “” is large (MB) and is being downloaded.

Please refresh this page in a few minutes to see if the filing has been downloaded. The filing will also be emailed to you when the download completes.

Your document is on its way!

If you do not receive the document in five minutes, contact support at support@docketalarm.com.

Sealed Document

We are unable to display this document, it may be under a court ordered seal.

If you have proper credentials to access the file, you may proceed directly to the court's system using your government issued username and password.


Access Government Site

We are redirecting you
to a mobile optimized page.





Document Unreadable or Corrupt

Refresh this Document
Go to the Docket

We are unable to display this document.

Refresh this Document
Go to the Docket